Olfactory receptors in macrophages and inflammation
- Marco Orecchioni(corresponding author),
- Hiroaki Matsunami,
- Klaus Ley(corresponding author)
- ,
- ,
- La Jolla Institute for Allergy and Immunology,
- Duke University,
- ,
Scholary Output:
Contribution to journal
Review article
Research
Peer-reviewOpen access
Abstract
<p>Olfactory receptors (ORs) that bind odorous ligands are the largest family of G-protein-coupled receptors. In the olfactory epithelium, approximately 400 and 1,100 members are expressed in humans and mice, respectively. Growing evidence suggests the extranasal functions of ORs. Here, we review OR expression and function in macrophages, specialized innate immune cells involved in the detection, phagocytosis, and destruction of cellular debris and pathogens as well as the initiation of inflammatory responses. RNA sequencing data in mice suggest that up to 580 ORs may be expressed in macrophages. Macrophage OR expression is increased after treatment with the Toll-like receptor 4 ligand lipopolysaccharide, which also induces the transcription of inflammasome components. Triggering human OR6A2 or its mouse orthologue Olfr2 with their cognate ligand octanal induces inflammasome assembly and the secretion of IL-1β, which exacerbates atherosclerosis. Octanal is positively correlated with blood lipids like low-density lipoprotein –cholesterol in humans. Another OR, Olfr78, is activated by lactate, which promotes the generation of tumor-associated macrophages that dampen the immune response and promote tumor progression. Olfactory receptors in macrophages are a rich source of untapped opportunity for modulating inflammation. It is not known which of the many ORs expressed in macrophages promote or modulate inflammation. Progress in this area also requires deorphanizing more ORs and determining the sources of their ligands.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Review article
Research
Peer-reviewOriginal language
English (US)Article number
1029244Journal (Volume, Issue Number)
Frontiers in immunology (Volume 13)Publication milestones
- Published - 10/13/2022
Publication status
Published - 10/13/2022
Publication IDs
- Scopus: 85140729643
- PubMed: 36311776
Publication metrics
Metrics
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
1
PlumX, opens in new tab
Mentions
1
Social media
2
Captures
47
Citation count
51
Funding Details
This study was funded by the National Institutes of Health R01 HL115232 (to KL), DC016224 and DC020353 (to HM), and the American Heart Association Career Development Award AHA Award Number: 941152 (to MO).
FundersFunding numbers
NIH
R01 HL115232, DC016224
NIDCD
R01DC020353
CIT
-AHA
941152
CSR
-OER
-ORIP, NIH, NIH-ORIP, ORIP
-